Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization

Table 1 Inflammation-based prognostic scores

Scoring systems	Score
Glasgow Prognostic Score
CRP ( ≤ 10 mg/L) and albumin (≥ 35 g/L)	0
CRP ( ≤ 10 mg/L) and albumin (< 35 g/L)	1
CRP (> 10 mg/L) and albumin (≥ 35 g/L)	1
CRP (> 10 mg/L) and albumin (< 35 g/L)	2
Modified Glasgow Prognostic Score
CRP ( ≤ 10 mg/L) and albumin (≥ 35 g/L)	0
CRP ( ≤ 10 mg/L) and albumin (< 35 g/L)	0
CRP (> 10 mg/L)	1
CRP (> 10 mg/L) and albumin (< 35 g/L)	2
Neutrophil-lymphocyte ratio
Neutrophil count:lymphocyte count < 3:1	0
Neutrophil count:lymphocyte count ≥ 3:1	1
Plt-lymphocyte ratio
Plt count:lymphocyte count < 150:1	0
Plt count:lymphocyte count ≥ 150:1	1
Plt count:lymphocyte count > 300:1	2
Prognostic index
CRP ( ≤ 10 mg/L) and WBC ( ≤ 11 × 109/L)	0
CRP ( ≤ 10 mg/L) and WBC (> 11 × 109/L)	1
CRP (> 10 mg/L) and WBC ( ≤ 11 × 109/L)	1
CRP (> 10 mg/L) and WBC (> 11 × 109/L)	2
Prognostic Nutritional Index
Albumin (g/L) × total lymphocyte count × 109/L ≥ 45	0
Albumin (g/L) × total lymphocyte count × 109/L < 45	1

CRP: C-reactive protein; Plt: Platelet; WBC: White blood cell count.